Live Price
Live Volume
Chart Volume 0
Volume 0
5 secNektar Therapeutics Market Segments
Premarket
-0.40(-1.07%)
| Open | $37.50 |
|---|---|
| Close | $37.10 |
| Low | $37.00 |
| Low Change | -0.50 (-1.33%) |
| High | $37.50 |
| High Change | +0.00 (+0.00%) |
| Range | $0.50 |
| Volume | 8.225K |
| Dollar Volume | $305.15K |
Overnight
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $37.26 |
|---|---|
| Close | $37.26 |
| Low | $37.26 |
| Low Change | 0.00 (0.00%) |
| High | $37.26 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 98.536K |
| Dollar Volume | $3.67M |
Regular Trading Hours Yesterday
+0.66(+1.79%)
| Open | $36.58 |
|---|---|
| Close | $37.24 |
| Low | $36.44 |
| Low Change | -0.14 (-0.38%) |
| High | $37.58 |
| High Change | +1.00 (+2.73%) |
| Range | $1.14 |
| Volume | 488.874K |
| Dollar Volume | $18.20M |
Premarket Yesterday
+0.50(+1.37%)
| Open | $36.50 |
|---|---|
| Close | $37.00 |
| Low | $36.39 |
| Low Change | -0.11 (-0.30%) |
| High | $37.45 |
| High Change | +0.95 (+2.60%) |
| Range | $1.06 |
| Volume | 7.361K |
| Dollar Volume | $272.36K |
Nektar Therapeutics News
1 month agoinvesting.comNektar Therapeutics stock analysis: oversold technicals meet binary clinical risk
- 2 months agoinvesting.com
Nektar Therapeutics stock rises on $90M jury verdict vs Lilly
- 2 months agoinvesting.com
Why is Nektar Therapeutics stock climbing today?
- 2 months agoinvesting.com
Nektar Therapeutics options flow shows bullish bets against a bearish tape
- 7 months agoinvesting.com
Nektar Therapeutics stock surges on alopecia drug trial data
- 9 months agoinvesting.com
Nektar Therapeutics stock falls after $400 million public offering
Nektar Therapeutics Top Trades
Nektar Therapeutics's top trade so far today returned +0.27%, while the top short trade returned -1.33%.
Nektar Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $37.32 |
|---|---|
| 10 Day Moving Average (SMA10) | $37.87 |
| 20 Day Moving Average (SMA20) | $37.84 |
| 50 Day Moving Average (SMA50) | $52.00 |
| 100 Day Moving Average (SMA100) | $61.25 |
| 200 Day Moving Average (SMA200) | $65.02 |
Nektar Therapeutics Statistics
| Average Volume (30 Days) | 1.57M |
|---|---|
| P/E Ratio (Current) | -8.95 |
| EPS (Current) | -$4.60 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$234.03M |
| Cash Ratio | 0.55 |
| Current Ratio | 10.42 |
| Quick Ratio | 10.42 |
| Debt to Equity | 0.00 |
| Enterprise Value | $1.37B |
| EV to EBITDA | -10.51 |
| EV to Sales | 25.03 |
| Price to Book | 1.56 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 25.75 |
| Return on Assets | -0.14% |
| Return on Equity | -0.17% |
Nektar Therapeutics Stock Splits
There has been 1 stock split for Nektar Therapeutics (NKTR). The reverse stock split occured on June 9, 2025 and reduced the outstanding shares at a ratio of 15:1.
| Date | Type | Ratio |
|---|---|---|
| Jun 9, 2025 | Reverse | 15:1 |
Nektar Therapeutics Dividends
There have been no dividends for Nektar Therapeutics (NKTR).